LONDON, May 15, 2023 /PRNewswire/ — The home health hub market is a rapidly growing sector that is revolutionizing the way healthcare is delivered to patients in their homes. Home health hubs, also known as home health gateways, are innovative technology platforms that connect patients, caregivers, and healthcare providers in real-time. These hubs offer a range … Read more
DUBLIN, May 15, 2023 /PRNewswire/ — The “Global Invasive Fungal Infections Market: Analysis By Molecule Class, By Infection Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028” report has been added to ResearchAndMarkets.com’s offering. Invasive fungal infections (IFIs) are serious and potentially life-threatening infections caused by fungi that invade deep … Read more
Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck to evaluate HMBD-001, a potentially best-in-class anti-HER3 mAb, in combination with cetuximab, an anti-EGFR mAb, in sqNSCLC HMBD-001 used as monotherapy and in combination with cetuximab has been shown to effectively inhibit tumor growth across various preclinical squamous cell carcinoma models SAN FRANCISCO, … Read more
Poster presentation covers data on VGX-0111, the Company’s gene therapy candidate for Dry Age-related Macular Degeneration (AMD), an aging related disorder and a leading cause of vision loss SAN DIEGO, May 15, 2023 /PRNewswire/ — Visgenx, Inc., a biotechnology company focused on developing gene therapies for degenerative retinal diseases, today announced that the Company will … Read more
LONDON, May 15, 2023 /PRNewswire/ — Acute repetitive seizures are an affliction that can strike fear into the hearts of those who suffer from them. These seizures are characterized by recurrent bouts of convulsions, muscle spasms, and loss of consciousness, all of which can happen multiple times in a short span of time. The condition can … Read more
Innovators Iyah Romm, Co-Founder and former CEO of Cityblock Health, and Ryan Watts, Co-Founder and CEO of Denali Therapeutics, poised to Help Rippl Transform care for seniors with neurocognitive challenges SEATTLE, May 15, 2023 /PRNewswire/ — Rippl, a new kind of behavioral health company focused on dramatically expanding access to high quality, wrap-around care for … Read more
LONDON, May 15, 2023 /PRNewswire/ — Alzheimer’s disease is a devastating neurodegenerative disorder that affects millions of people worldwide. As the population ages, the incidence of Alzheimer’s disease is expected to rise, creating a growing need for effective treatments. This presents a significant opportunity for the development of innovative therapies that can improve the lives of … Read more
Collaboration agreement strengthens 61Cu-supply chain capabilities for clinical development in North America BASEL, Switzerland and BOCA RATON, Fla., May 15, 2023 /PRNewswire/ — NUCLIDIUM and PharmaLogic Holdings today announced that they have entered into a strategic collaboration agreement for the production and clinical supply of 61Cu in the United States to accelerate the development of … Read more
PRAGUE, May 15, 2023 /PRNewswire/ — On 15–17 September, Prague will become the world center of traditional, complementary, integrative and alternative medicine (TCIM/CAM). Prague will be the venue of the 3rd World Health Congress 2023 Prague www.whc2023prague.com. The motto of this year’s Congress edition is: Accomplishments and current trends in TCIM for the 21st century – … Read more
LONDON, May 15, 2023 /PRNewswire/ — Optimum Strategic Communications (“Optimum”), the specialist life sciences communications consultancy, today announces the appointment of highly-experienced medical journalist, Stephen Adams, as a full-time member of its team. Stephen, who joins as an Associate Director with immediate effect, spent 10 years at The Mail on Sunday, first as Health Correspondent … Read more